EDGAR Filing Documents for 0000932352-13-000002

Form D - Notice of Exempt Offering of Securities:

SEC Accession No. 0000932352-13-000002

Filing Date

2013-07-19

Accepted

2013-07-19 16:45:13

Documents

Effectiveness Date

2013-07-19

Items

Item 06: Rule 506

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	D
1		primary_doc.xml	D	5775
	Complete submission text file	0000932352-13-000002.txt		7064

Mailing Address 501 SILVERSIDE ROAD PMB#95 WILMINGTON DE 19809

Business Address 501 SILVERSIDE ROAD PMB#95 WILMINGTON DE 19809 (925) 280-2861

Urigen Pharmaceuticals, Inc. (Filer) CIK: 0000932352 (see all company filings)